Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Desmoid Tumor: early-phase trial registry
1 of 5 indexed Desmoid Tumor trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 1 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Desmoid Tumor: 5 US clinical trials tracked, 1 recruiting.
Desmoid Tumor is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is Immunome, running 1 of these trials.
Enrollment posture brief
Registry condition desmoid-tumor
OPEN 1 | RECR 20% | LATE 0 | EARLY 5 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (20% recruiting · 10 trials)
Desmoid Tumor lists 1 open slots (20% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Desmoid Tumor on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Desmoid Tumor is recruiting below its size-band peers.
1 of 5 indexed trials (20%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Desmoid Tumor research.
Immunome accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Most Desmoid Tumor trials plan to enrol fewer than 100 people.
Median target enrolment is 53 among the 5 trials that report a genuine target (sentinel values excluded). 4 of those (80%) plan for fewer than 100 participants.
-
Desmoid Tumor research is mostly interventional.
5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Study of Cryoablation and Nirogacestat for Desmoid Tumor
Nam Bui
NCT05949099
A Study of AL102 in Patients With Progressing Desmoid Tumors
Immunome
NCT04871282
Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor
Children's Oncology Group
NCT00068419
Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas
Memorial Sloan Kettering Cancer Center
NCT00474994
A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis
MaineHealth
NCT01265030
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 4 |
Top Sponsors
Named interventions
Most-linked intervention names on Desmoid Tumor records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Desmoid Tumor trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Desmoid Tumor page
5 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Desmoid Tumor trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Immunome sponsors the most Desmoid Tumor trials on record, review their full trial history before evaluating a specific study. See Immunome's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Desmoid Tumor condition card totals 5 registered trials; most-linked intervention sulindac; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.